17-42680152-T-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_016602.3(CCR10):āc.490A>Gā(p.Ile164Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000571 in 1,612,050 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_016602.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CCR10 | NM_016602.3 | c.490A>G | p.Ile164Val | missense_variant | 2/2 | ENST00000332438.4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CCR10 | ENST00000332438.4 | c.490A>G | p.Ile164Val | missense_variant | 2/2 | 1 | NM_016602.3 | P1 | |
ENST00000593139.1 | n.190T>C | non_coding_transcript_exon_variant | 1/3 | 5 | |||||
CCR10 | ENST00000591568.1 | c.-177A>G | 5_prime_UTR_variant | 2/2 | 3 | ||||
CCR10 | ENST00000591765.1 | c.-177A>G | 5_prime_UTR_variant | 2/2 | 3 |
Frequencies
GnomAD3 genomes AF: 0.0000724 AC: 11AN: 152008Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000123 AC: 3AN: 242954Hom.: 0 AF XY: 0.00000753 AC XY: 1AN XY: 132888
GnomAD4 exome AF: 0.0000555 AC: 81AN: 1460042Hom.: 0 Cov.: 31 AF XY: 0.0000482 AC XY: 35AN XY: 726370
GnomAD4 genome AF: 0.0000724 AC: 11AN: 152008Hom.: 0 Cov.: 33 AF XY: 0.0000673 AC XY: 5AN XY: 74252
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 15, 2021 | The c.490A>G (p.I164V) alteration is located in exon 2 (coding exon 2) of the CCR10 gene. This alteration results from a A to G substitution at nucleotide position 490, causing the isoleucine (I) at amino acid position 164 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at